Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of an in vitro model to test the efficacy of novel therapies for IVD degeneration.

Journal of tissue engineering and regenerative medicine - 1 Aug 2009

Le Maitre Christine L, Fotheringham Andrew P, Freemont Anthony J, Hoyland Judith A

Abstract excerpt

Low back pain (LBP) is a major cause of disability worldwide that has been linked to intervertebral disc (IVD) degeneration. An improved understanding of the pathogenesis of disc degeneration is now developing, which is leading to the development of a number of possible future therapies targeted...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aggrecans
Share to Collagen Type I
Share to Collagen Type II

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hydrostatic Pressure

Share to Intervertebral Disc Displacement

Share to Poly A

Share to Proteoglycans

Share to Tissue Engineering

Source

Open in PubMed Open full text

Identifiers

PMID: 19444863
DOI: 10.1002/term.180
PMCID: PMC3072656

Genes

IVD
LBP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19444863-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of an in vitro model to test the efficacy of novel therapies for IVD degeneration.PMID 19444863Read ↗

A Brief Review of the Degenerative Intervertebral Disc Disease.Semantic proximity Read ↗

The nucleus pulposus microenvironment in the intervertebral disc: the fountain of youth?Semantic proximity Read ↗

The regeneration of degenerated intervertebral discs via tissue engineering, biomaterials, and gene or cell-based therapiesSemantic proximity Read ↗

NTG-102: A Refined Molecular Therapeutic to Treat Degenerative Disc DiseaseSemantic proximity Read ↗

Stem Cells and Exosomes: New Therapies for Intervertebral Disc DegenerationSemantic proximity Read ↗

Macrophages Down-Regulate Gene Expression of Intervertebral Disc Degenerative Markers Under a Pro-inflammatory MicroenvironmentSemantic proximity Read ↗

An In Vitro Organ Culture Model of the Murine Intervertebral Disc.Semantic proximity Read ↗

Variations in gene and protein expression in canine chondrodystrophic nucleus pulposus cells following long-term three-dimensional culture.Semantic proximity Read ↗

Regenerative potential of TGFβ3 + Dex and notochordal cell conditioned media on degenerated human intervertebral disc cells.Semantic proximity Read ↗

Understanding nucleus pulposus cell phenotype: a prerequisite for stem cell based therapies to treat intervertebral disc degeneration.Semantic proximity Read ↗

Understanding the native nucleus pulposus cell phenotype has important implications for intervertebral disc regeneration strategies.Semantic proximity Read ↗

Lactate Metabolism in the Intervertebral Disc: Mechanistic Insights and Pathological ImplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.